Old asthma drug may help kids with rare growth disorder
NCT ID NCT03029429
Summary
This study is testing whether theophylline, a medication long used for asthma, can help manage symptoms of a rare genetic condition called pseudohypoparathyroidism. Researchers are giving the drug to 29 children and young adults with the condition for one year to see if it helps with weight loss, improves blood sugar control, and slows early bone growth plate closure. The goal is to find a new way to control the obesity and growth problems that current hormone treatments don't address.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSEUDOHYPOPARATHYROIDISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ashley Shoemaker
Nashville, Tennessee, 37212, United States
Conditions
Explore the condition pages connected to this study.